FDA Approved: NASACORT ALLERGY 24HR — Supplemental Application (Chattem, Inc.)

View source ↗

Summary

FDA approved a supplemental application for NASACORT ALLERGY 24HR (triamcinolone acetonide) submitted by Chattem, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Perennial Allergic Rhinitis
• Seasonal Allergic Rhinitis

Drugs mentioned

• NASACORT ALLERGY 24HR (TRIAMCINOLONE ACETONIDE)

Snippet

SUPPL AP for NASACORT ALLERGY 24HR (TRIAMCINOLONE ACETONIDE)